VivoSim Labs (VIVS) Capital Leases (2012 - 2014)
VivoSim Labs (VIVS) posted quarterly Capital Leases of $1000.0 for Q3 2014, down 90.0% year-over-year from $10000.0 in Q3 2013, and down 50.0% quarter-over-quarter from $2000.0 in Q2 2014.
VivoSim Labs (VIVS) Capital Leases (2012 - 2014) Analysis & Trends
VivoSim Labs' Capital Leases history runs 3 years deep, the most recent figure standing at $1000.0 for Q3 2014.
- In Q3 2014, Capital Leases fell 90.0% year-over-year to $1000.0; the TTM figure through Sep 2014 stood at $1000.0 (down 90.0% YoY), while the FY2014 annual figure was $5000.0, down 66.67% from the prior year.
- Capital Leases for Q3 2014 stood at $1000.0, down from $2000.0 in the prior quarter.
- The five-year high for Capital Leases was $19712.0 in Q3 2012, with the low at $1000.0 in Q3 2014.
- The 3-year median for Capital Leases is $9000.0 (2013), against an average of $9714.0.
- The sharpest annual moves came in 2013 and 2014: Capital Leases tumbled 49.27% in 2013, then tumbled 90.0% in 2014.
- VivoSim Labs' Capital Leases stood at $17000.0 in 2012, then tumbled by 52.94% to $8000.0 in 2013, then tumbled by 87.5% to $1000.0 in 2014.
- Business Quant data shows VIVS's Capital Leases at $1000.0 in Q3 2014, $2000.0 in Q2 2014, and $5000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 2,000.00 |
| Mar 31, 2014 | 5,000.00 |
| Dec 31, 2013 | 8,000.00 |
| Sep 30, 2013 | 10,000.00 |
| Mar 31, 2013 | 15,000.00 |
| Dec 31, 2012 | 17,000.00 |
| Sep 30, 2012 | 19,712.00 |